How to Get Finasteride in Maryland

What Finasteride Is and Why a Prescription Is Required

Finasteride is a 5-alpha-reductase type II inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen primarily responsible for follicle miniaturization in male pattern hair loss and for prostatic tissue proliferation in BPH. The FDA approved the 1 mg dose for androgenetic alopecia in December 1997 and the 5 mg dose for BPH in 1992. [1][2] Because the drug carries a Pregnancy Category X classification, affects hormone metabolism, and requires monitoring for PSA changes in men over 50, federal and Maryland law classify it as prescription-only.

Kaufman et al. enrolled 1,553 men aged 18 to 41 in a key two-year trial and found that 83% of finasteride-treated participants maintained or increased their hair count versus only 28% in the placebo group (P<0.001). [3] A separate placebo-controlled study (N=1,879) reported a mean 107-hair increase in a 1-inch scalp circle after 12 months. [4] These results form the primary evidentiary basis that the FDA relied on when issuing the Propecia label.

Obtaining the drug without a valid prescription is illegal under the Maryland Pharmacy Act, Title 12 of the Health Occupations Article. A licensed prescriber's involvement protects the patient from counterfeit sources and ensures that contraindications (e.g., liver disease, pediatric age, pregnancy exposure) are screened before treatment begins.

Maryland Telehealth Rules for Finasteride

Maryland permits telehealth prescribing of finasteride under the Maryland Telehealth Advancement Act and guidance from the Maryland Board of Physicians. [5] A prescriber must hold an active Maryland license, establish a valid patient-provider relationship during the visit, and document a clinical assessment before sending the prescription to a pharmacy. Controlled substances require in-person evaluation under the Ryan Haight Act, but finasteride is not a controlled substance, so the entire process can happen by video or asynchronous questionnaire.

Typical telehealth platforms operating legally in Maryland complete the clinical intake, prescriber review, and e-prescription transmission in under two hours. The patient then fills the prescription at any Maryland-licensed retail pharmacy or an accredited mail-order pharmacy. Maryland law does not require a physical examination specifically for finasteride; the medical history, description of hair loss pattern, and photos (for AGA) or IPSS symptom score (for BPH) may be sufficient for the initial encounter at the prescriber's clinical discretion.

The Maryland Board of Physicians has stated that prescribers using telehealth must meet the same standard of care they would apply in an office setting. [5] That standard does not mandate an in-office visit for a straightforward AGA case in an otherwise healthy adult male.

Step-by-Step: How to Get a Finasteride Prescription in Maryland

Step 1. Choose an in-person or telehealth provider

Maryland-licensed MDs, DOs, NPs with full prescriptive authority, and PAs operating under a supervising physician agreement may all prescribe finasteride. For a straightforward AGA case, a board-certified dermatologist, urologist, primary care physician, or a state-licensed telehealth platform are all appropriate starting points. The Maryland Board of Nursing grants NPs prescriptive authority upon completion of required pharmacology training, so NP-led telehealth services are fully legal in the state. [6]

Step 2. Complete the clinical intake

At minimum, the prescriber will collect: chief complaint and duration of hair loss or urinary symptoms, current medication list (to screen for interactions with other 5-alpha-reductase agents or alpha-blockers), personal or family history of prostate cancer, and baseline PSA if the patient is 40 or older or symptomatic for BPH. The FDA label for finasteride 5 mg notes that the drug can reduce PSA by approximately 50% after 6 to 12 months, which must be accounted for when interpreting PSA screening results. [2]

Step 3. Receive and fill the e-prescription

Maryland participates in the Interstate Medical Licensure Compact, which means many out-of-state telehealth providers hold or can obtain a Maryland license quickly. Once the e-prescription is transmitted, the patient fills it at any Maryland-licensed retail pharmacy. Major chains (CVS, Walgreens, Rite Aid, Giant Food Pharmacy) and independent pharmacies throughout Baltimore, Bethesda, Silver Spring, Annapolis, and Frederick routinely stock generic finasteride in both the 1 mg and 5 mg strengths. Generic 1 mg finasteride is available for as little as $15 to $30 per 30-day supply at GoodRx-contracted Maryland pharmacies.

Step 4. Arrange monitoring and refills

Follow-up is recommended at 3 months (for tolerability) and 12 months (to assess efficacy for AGA, or to recheck PSA for BPH). Most telehealth platforms send automated check-in questionnaires at these intervals. The American Urological Association guideline on BPH recommends annual PSA monitoring in men on finasteride 5 mg to maintain accurate prostate cancer screening. [7]

Labs and Tests Before Starting Finasteride in Maryland

No universal pre-treatment laboratory panel is mandated by state law before prescribing finasteride. Clinical practice does vary. For AGA in a healthy male under 40 with no systemic symptoms, many dermatologists prescribe without any bloodwork. For men over 40, or any patient with BPH symptoms, a baseline PSA is standard. The AUA guideline states that "a serum PSA measurement should be obtained prior to initiating 5-alpha-reductase inhibitor therapy in men for whom prostate cancer screening is otherwise appropriate." [7]

Some Maryland prescribers also order a testosterone panel, complete blood count, and basic metabolic panel at baseline, particularly when hair loss appears diffuse rather than following the Norwood-Hamilton pattern, which may suggest a secondary cause such as thyroid disease or nutritional deficiency. [8] The American Academy of Dermatology's clinical guideline on androgenetic alopecia recommends ruling out reversible causes (iron deficiency, thyroid dysfunction, zinc deficiency) before attributing hair loss solely to DHT-driven miniaturization. [9]

Patients with known or suspected liver disease should have liver function tests reviewed, as finasteride is hepatically metabolized via CYP3A4. The FDA label notes that no dose adjustment is required for mild hepatic impairment, but data on severe hepatic impairment are limited. [2]

Compounding Finasteride in Maryland: 503A Pharmacy Rules

Maryland-licensed 503A compounding pharmacies may prepare finasteride formulations that are not commercially available when a prescriber writes a patient-specific prescription with a valid medical rationale. Common reasons for compounding include:

• Topical finasteride 0.1% to 0.25% solution or foam, sought by patients wishing to minimize systemic DHT suppression and potential sexual side effects
• Custom-dose oral formulations for patients with tablet-swallowing difficulties
• Combination topical preparations (e.g., finasteride plus minoxidil) in a single vehicle

A 2021 randomized trial (N=300) found that 0.25% topical finasteride solution reduced scalp DHT by 60% while producing significantly lower serum DHT suppression compared with 1 mg oral finasteride, suggesting a potentially favorable systemic side-effect profile for some patients. [10] Maryland 503A pharmacies must comply with USP Chapter 795 (non-sterile compounding standards) and hold an active Maryland Board of Pharmacy permit. [11] Prescribers should verify pharmacy licensure on the Maryland Board of Pharmacy public database before directing patients to a specific compounder.

503B outsourcing facilities operate under different FDA oversight and serve large healthcare institutions. For individual patient prescriptions, 503A is the relevant category in Maryland. The FDA maintains a list of registered 503B facilities, but those are generally not the source for patient-specific compounded finasteride. [12]

Maryland Medicaid and Insurance Coverage for Finasteride

Maryland Medicaid covers finasteride 5 mg for BPH with prior authorization (PA). The PA process requires documentation of a BPH diagnosis (ICD-10 code N40.0 or N40.1), symptom severity using an IPSS score of 8 or higher, and absence of prostate cancer. Coverage for finasteride 1 mg for androgenetic alopecia is less consistent. Many Maryland Medicaid managed care organizations classify AGA treatment as cosmetic and deny coverage, which is consistent with national Medicaid policy trends. [13]

Private insurers in Maryland vary considerably. Plans regulated by the Maryland Insurance Administration generally follow formulary decisions made at the national plan level. Generic finasteride 5 mg appears on most Tier 1 or Tier 2 formulary lists for BPH. Brand-name Propecia (1 mg) is rarely covered, but generic finasteride 1 mg may be covered under some plans when the prescriber specifies the indication explicitly. Patients are encouraged to use the Maryland Insurance Administration's consumer resources or call the plan directly to verify formulary tier and PA requirements before the prescription is sent. [14]

For uninsured or underinsured Maryland residents, GoodRx coupons routinely bring generic finasteride 1 mg to under $25 per 30-day supply at major Maryland pharmacy chains, and the Merck Patient Assistance Program covers brand-name Proscar for qualifying low-income patients. [15]

Transferring an Existing Finasteride Prescription to Maryland

Patients relocating to Maryland from another state can transfer an existing finasteride prescription to a Maryland-licensed pharmacy under NABP and Maryland Pharmacy Act rules, provided the prescription has remaining refills, the issuing state's pharmacy shares transfer data with a Maryland pharmacy, and the original prescription was issued by a licensed prescriber. [16] If the out-of-state prescription has no refills remaining, the patient must establish care with a Maryland-licensed prescriber to receive a new prescription.

Telehealth platforms that hold Maryland licenses can complete the new-patient visit quickly, often the same day. Maryland does not require a waiting period between prescriber visit and prescription dispensing for non-controlled medications like finasteride. Many patients who transfer care through a telehealth platform receive their new prescription within 24 hours of completing the online intake.

Side Effects, Monitoring, and When to Seek Guidance

Finasteride is generally well tolerated. The most discussed adverse effects are sexual side effects, including decreased libido, erectile dysfunction, and ejaculatory disorder, each reported in roughly 1% to 3.8% of participants in controlled trials versus 0.7% to 2.1% in placebo groups. [2][3] Most sexual side effects resolve after discontinuation, though a small subset of patients report persistent symptoms, a phenomenon sometimes called post-finasteride syndrome. The FDA updated the Propecia label in 2011 to include these persistent effects in the safety section. [2]

A 2010 NCI-sponsored trial, the Prostate Cancer Prevention Trial (PCPT, N=18,882), found that finasteride 5 mg taken over 7 years reduced the period prevalence of prostate cancer by 24.8% but was associated with a higher rate of high-grade tumors (Gleason 7 to 10: 6.4% finasteride vs. 5.1% placebo). [17] Subsequent FDA analysis concluded that the high-grade cancer signal may reflect improved detection in smaller prostate glands rather than drug-induced carcinogenesis, and the agency did not withdraw the drug; however, the label carries a safety update for this finding. [2] Maryland prescribers managing BPH patients on finasteride 5 mg should document this discussion in the clinical note.

Gynecomastia is reported in fewer than 1% of patients in AGA trials but is listed in the label. Any new breast tissue growth or breast tenderness should prompt evaluation and possible discontinuation.

Choosing Between In-Person and Telehealth Care in Maryland

For most healthy Maryland men seeking finasteride for AGA, telehealth is convenient and medically appropriate. In-person care carries specific advantages: the dermatologist can perform dermoscopy to confirm the Norwood-Hamilton pattern, rule out alopecia areata or scarring alopecias, and perform a scalp biopsy if needed. For BPH, a urologist can perform a digital rectal examination and interpret PSA in context. No telehealth platform replaces those assessments when clinical uncertainty exists.

A 2023 JAMA Dermatology cross-sectional study found that teledermatology encounters for hair loss produced diagnostic agreement with in-person dermatology in 89% of cases when standardized photo protocols were used. [18] That figure supports telehealth as a reasonable first step for a patient with a typical Norwood II to V pattern and no systemic symptoms, while in-person evaluation remains the appropriate path when the pattern is atypical or lab findings are abnormal.

Maryland residents living in areas with limited dermatology access, including parts of the Eastern Shore and Western Maryland, may find telehealth to be their most practical option. The Maryland Health Care Commission reported in 2023 that 12 of Maryland's 24 jurisdictions have dermatologist-to-population ratios below the national median, making telehealth access particularly relevant for those communities.

Pricing and Pharmacy Options in Maryland

Generic finasteride 1 mg is manufactured by Aurobindo, Accord, Dr. Reddy's, and several other FDA-approved generic manufacturers. Retail cash prices in Maryland as of early 2025 range from approximately $15 to $60 per 30-day supply depending on pharmacy and coupon use. The FDA's Orange Book confirms the bioequivalence of all currently marketed generic finasteride 1 mg tablets to the Propecia reference listed drug. [19]

Maryland residents can fill finasteride prescriptions at brick-and-mortar pharmacies or through NABP-accredited (.pharmacy domain) mail-order pharmacies that ship to Maryland addresses. The National Association of Boards of Pharmacy's Verified Internet Pharmacy Practice Sites (VIPPS) program allows patients to confirm the legitimacy of online pharmacies before ordering. [16] Patients should avoid websites offering finasteride without a prescription; these sources frequently supply counterfeit or substandard products and operate outside FDA oversight.